ACET
Adicet Bio · USD
Deep AI analysis (big model)
No deep analysis yet. Portfolio holdings are analysed automatically; for any other stock, click “Request deep AI analysis” above.
About Adicet Bio
Adicet Bio is a biopharmaceutical company focused on developing and commercializing novel cancer immunotherapies, with its main product being an investigational drug for treating certain types of cancer.
| Ticker | ACET |
| Name | Adicet Bio |
| Currency | USD |
| Sector | Healthcare |
Reputation
Reputation builds as news about this company is analysed.
Price history & forecast
30-day forecast — Linear regression, Holt's exponential smoothing, and drift, plus a news-adjusted consensus (sentiment tilt +0.00). Estimates only, not advice.
Candlestick, volume & news sentiment
Open/high/low/close candles with volume beneath; hover for OHLC, change and volume. Dots mark analysed news by sentiment; shaded bands are when the market was closed. Day and Week show intraday detail; Month+ show daily candles. Step through time with ‹ ›.
Forecast accuracy (backtested)
No scored forecasts yet. Every visit records the day's forecast; once those predicted dates pass, this table fills in with how each method actually did (1 snapshot(s) recorded so far, none matured yet).
Technical analysis
BEARISHComputed from 255 locally-stored price bars.
AI signals
-
HOLD 80% · long_term 2026-06-08 10:02
The stock has been in a downtrend for several days, with recent close at 7.26 which is lower than the previous day's closing price of 7.26 on June 5th. There are no recent positive news or analyst reports to support an increase in price. The bear case seems more dominant given the lack of supportive market sentiment and the stock's recent performance.
qwen2.5:3b
Related news
- No matched headlines yet.